病例报告: 一种罕见的原发性急性巨细胞白血病的经验

Zhijuan Pan1, Ying Zhang1, Yanru Guo1

  • 1Department of Hematology, Peking University First Hospital Taiyuan Branch (Taiyuan Central Hospital of Shanxi Medical University), No. 256, Fendong Street, Xiaodian District, Taiyuan, Shanxi 030009, PR China.

PubMed
概括

甲基普雷迪尼索隆可能比德克萨米他更有效地治疗巨细胞白血病 (MCL),这是一种罕见的癌症. 这一发现表明,个性化皮质类固醇治疗对于改善MCL患者的治疗结果至关重要.